Cagrilintide 10 mg

Cagrilintide is a long-acting research peptide currently being investigated in scientific and clinical research related to weight loss, satiety, appetite regulation and metabolic regulation.

Cagrilintide acts through the amylin pathway, placing it in a different research category from GLP-1, GIP and glucagon-related compounds.

What is Cagrilintide?

Cagrilintide is a long-acting amylin receptor agonist.

Amylin is a naturally occurring peptide hormone involved in several metabolic processes, including signalling associated with satiety and food intake.

Cagrilintide has been developed for research into prolonged activation of the amylin pathway and is currently being investigated in clinical research programmes involving weight loss and metabolic health.

Cagrilintide in Weight-Loss Research

Cagrilintide is currently being investigated in clinical research programmes focused on weight loss and obesity research.

Its mechanism differs from several other well-known metabolic research compounds.

Cagrilintide
→ Amylin pathway

Semaglutide
→ GLP-1 pathway

Tirzepatide
→ GLP-1 + GIP pathways

Retatrutide
→ GLP-1 + GIP + glucagon pathways

Cagrilintide therefore represents a distinct research pathway within modern metabolic and weight-loss research.

Research Areas

• Weight-loss research
• Obesity research
• Appetite regulation
• Satiety research
• Food-intake signalling
• Energy balance
• Metabolic regulation
• Amylin receptor signalling
• Complementary metabolic pathways

Product Information

Product: Cagrilintide
Contents: 10 mg
Form: Lyophilised peptide
Category: Research Peptide
Research Area: Weight Loss & Metabolic Research
Mechanism: Amylin receptor agonist
Price: €99.95
Batch information: Product-specific

Cagrilintide remains under clinical investigation and is not an approved medicine for weight loss or the treatment of obesity.

For research purposes only. Not intended for human consumption.